Omnicell, Inc.

OMCL - Financial Snapshot

Metrics for OMCL

Price $46.25
Shares Outstanding 44.88M
Net Current Assets / Share $-1.52
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $5.69
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Max Earning Power / Share $6.28
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $1.16
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 1.02%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Ave Max Earning Power (5Y) $22.39
Ave Max Earning Power (5Q Annualized) $22.47
Ave Max Earning Power Delta (5Q Ann - 5Y) $0.08
Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Data as of: Price 12-18-25 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 12-19-2025
Income indicators Value Date
EBITDA Positive Yes 12-19-2025
Net Income Positive Yes 12-19-2025
Avg CA Burn (Annual %) 0.89% 12-19-2025
Avg CA Burn (Quarterly %) -12.15% 12-19-2025

Shares Outstanding Changes

Date Shares Outstanding Delta
2025-11-07 44,876,522 -1,057,729
2025-09-17 45,934,251 -49
2025-08-08 45,934,300 -909,300

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.